Publications
- Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Long time successful treatment of a young patient suffering from advanced ALK rearreged lung adenocarcinoma2018 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Biologická léčba karcinomu plic2018 | Second Faculty of Medicine
- Crizotinib in the treatment of generalized non-small-cell lung cancer - a case report2017 | Publication without faculty affiliation
- Imunoterapie v první linii léčby nemalobuněčného karcinomu plic2017 | Publication without faculty affiliation
- Pembrolizumab in the treatment of non-small-cell lung cancer2016 | Publication without faculty affiliation
- New treatment options for ALK-positive patients with NSCLC krizotinibem2016 | Publication without faculty affiliation
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?2022 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
Loading network view...